Stifel on X4 Pharmaceuticals (XFOR): 'today’s disclosure significantly de-risks the now enrolling P3 4WARD trial'

Go back to Stifel on X4 Pharmaceuticals (XFOR): 'today’s disclosure significantly de-risks the now enrolling P3 4WARD trial'

Form 8-K X4 Pharmaceuticals, Inc For: Jun 27

June 27, 2024 8:01 AM EDT

... More